Back to Journals » Drug Design, Development and Therapy » Volume 15 » Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study
Please verify you are not a robot.